Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Our staff is also available to answer any questions you might have
( )
Specialized programs for hormone optimization, sexual health, medical weight loss, longevity, and IV wellness all guided by licensed providers and grounded in comprehensive lab work
Resmetirom (Rezdiffra TM ), a liver-directed thyroid hormone receptor- (THR-) agonist, received accelerated FDA approval in March 2024 as the first agent specifically indicated for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2-F3), based on the MAESTRO-NASH trial demonstrating MASH resolution and fibrosis improvement
Meaningful weight loss generally requires reaching at least the 1.0 mg weekly dose, which takes about 8 weeks with standard titration
Learn more about BioTe Certified Provider and Medical Weight Loss Specialist Rachel Snyder, APRN, CNP, by CLICKING HERE
US$ 23.92
US$ 24.49
US$ 29.87
US$ 27.80
US$ 25.58
US$ 25.16
US$ 24.70
